Prelude Capital Management’s ResMed RMD Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | – | Sell |
-1,671
| Closed | -$374K | – | 1252 |
|
2025
Q1 | $374K | Buy |
1,671
+28
| +2% | +$6.27K | 0.03% | 532 |
|
2024
Q4 | $376K | Buy |
+1,643
| New | +$376K | 0.02% | 599 |
|
2024
Q3 | – | Sell |
-3,145
| Closed | -$602K | – | 1401 |
|
2024
Q2 | $602K | Sell |
3,145
-5
| -0.2% | -$957 | 0.04% | 405 |
|
2024
Q1 | $624K | Buy |
3,150
+1,385
| +78% | +$274K | 0.03% | 476 |
|
2023
Q4 | $304K | Sell |
1,765
-620
| -26% | -$107K | 0.02% | 631 |
|
2023
Q3 | $353K | Sell |
2,385
-143
| -6% | -$21.1K | 0.02% | 490 |
|
2023
Q2 | $552K | Buy |
+2,528
| New | +$552K | 0.04% | 364 |
|
2022
Q1 | – | Sell |
-1,366
| Closed | -$356K | – | 1838 |
|
2021
Q4 | $356K | Buy |
1,366
+102
| +8% | +$26.6K | 0.01% | 953 |
|
2021
Q3 | $333K | Buy |
1,264
+283
| +29% | +$74.6K | 0.01% | 817 |
|
2021
Q2 | $242K | Sell |
981
-2,639
| -73% | -$651K | 0.01% | 1050 |
|
2021
Q1 | $702K | Buy |
+3,620
| New | +$702K | 0.02% | 476 |
|
2020
Q4 | – | Sell |
-367
| Closed | -$63K | – | 1413 |
|
2020
Q3 | $63K | Buy |
+367
| New | +$63K | ﹤0.01% | 811 |
|
2017
Q1 | – | Hold |
0
| – | – | – | 1676 |
|
2016
Q4 | – | Hold |
0
| – | – | – | 1689 |
|
2016
Q3 | – | Hold |
0
| – | – | – | 1703 |
|
2016
Q2 | – | Sell |
-1,122
| Closed | -$65K | – | 1643 |
|
2016
Q1 | $65K | Buy |
+1,122
| New | +$65K | 0.01% | 826 |
|
2014
Q1 | – | Sell |
-2,700
| Closed | -$127K | – | 1869 |
|
2013
Q4 | $127K | Sell |
2,700
-1,699
| -39% | -$79.9K | 0.02% | 710 |
|
2013
Q3 | $232K | Buy |
+4,399
| New | +$232K | 0.04% | 434 |
|